Tina McKinnor
- Democratic
- Assemblymember
- District 61
Author
Existing law, the Pharmacy Law, requires the California State Board of Pharmacy to license and regulate the practice of pharmacy by pharmacists and pharmacy corporations in this state. Existing law prohibits a pharmacy from compounding sterile drug products unless the pharmacy has obtained a sterile compounding pharmacy license from the board. Existing law requires the compounding of drug preparations by a pharmacy for furnishing, distribution, or use to be consistent with standards established in the pharmacy compounding chapters of the current version of the United States Pharmacopeia-National Formulary, including relevant testing and quality assurance. Existing law authorizes the board to adopt regulations to impose additional standards for compounding drug preparations. This bill would, notwithstanding those provisions, specify that compounding does not include reconstitution of a drug pursuant to a manufacturer's directions, the sole act of tablet splitting or crushing, capsule opening, or the addition of a flavoring agent to enhance palatability. The bill would require a pharmacy to retain documentation that a flavoring agent was added to a prescription and to make that documentation available to the board or its agent upon request.
Consideration of Governor's veto stricken from file.
Consideration of Governor's veto pending.
Vetoed by Governor.
Enrolled and presented to the Governor at 3:30 p.m.
Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 79. Noes 0. Page 3532.).
From committee: That the Senate amendments be concurred in. (Ayes 19. Noes 0.) (September 13).
Assembly Rule 77 suspended. (Page 3011.)
Re-referred to Com. on B. & P. pursuant to Assembly Rule 77.2.
In Assembly. Concurrence in Senate amendments pending. May be considered on or after September 8 pursuant to Assembly Rule 77.
Read third time. Passed. Ordered to the Assembly. (Ayes 40. Noes 0. Page 2397.).
Read second time. Ordered to third reading.
From committee: Be ordered to second reading pursuant to Senate Rule 28.8.
From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on APPR.
In committee: Hearing postponed by committee.
From committee: Do pass and re-refer to Com. on APPR. (Ayes 13. Noes 0.) (July 10). Re-referred to Com. on APPR.
From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on B., P. & E. D.
Re-referred to Com. on RLS pursuant to Senate Rule 29.10c.
Read second time. Ordered to third reading.
Read second time and amended. Ordered returned to second reading.
Ordered to second reading.
From inactive file.
From Consent Calendar.
Ordered to inactive file at the request of Senator Ochoa Bogh.
Read second time. Ordered to Consent Calendar.
From committee: Do pass. To Consent Calendar. (Ayes 14. Noes 0.) (June 13).
Read third time. Passed. Ordered to the Senate. (Ayes 65. Noes 0. Page 1008.)
In Senate. Read first time. To Com. on RLS. for assignment.
Read second time. Ordered to Consent Calendar.
From committee: Do pass. To Consent Calendar. (Ayes 20. Noes 0.) (March 22).
From printer. May be heard in committee March 16.
Read first time. To print.
| Bill Text Versions | Format |
|---|---|
| AB782 | HTML |
| 02/13/23 - Introduced | |
| 06/19/23 - Amended Senate | |
| 06/27/23 - Amended Senate | |
| 08/21/23 - Amended Senate | |
| 09/18/23 - Enrolled |
| Document | Format |
|---|---|
| 03/21/23- Assembly Governmental Organization | |
| 06/08/23- Senate Governmental Organization | |
| 06/14/23- Sen. Floor Analyses | |
| 07/07/23- Senate Business, Professions and Economic Development | |
| 08/31/23- Sen. Floor Analyses | |
| 09/06/23- ASSEMBLY FLOOR ANALYSIS | |
| 09/11/23- Assembly Business and Professions | |
| 09/13/23- ASSEMBLY FLOOR ANALYSIS | |
| 10/20/23- ASSEMBLY FLOOR ANALYSIS |
Data on Open States is updated periodically throughout the day from the official website of the California State Legislature.
If you notice any inconsistencies with these official sources, feel free to file an issue.